Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins
EXPERIMENTAL allergic encephalitis (EAE) is an inflammatory autoimmunedisease of the central nervous system (CNS) that is mediated by T lymphocytes sensitised to the organ-specific basic protein (BP) of CNS myelin 2 . Lesions of delayed hypersensitivity develop in the brain and spinal cord when sens...
Gespeichert in:
Veröffentlicht in: | Nature (London) 1977-03, Vol.266 (5601), p.459-461 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 461 |
---|---|
container_issue | 5601 |
container_start_page | 459 |
container_title | Nature (London) |
container_volume | 266 |
creator | MACPHERSON, CATHERINE F.C. ARMSTRONG, HOLLY |
description | EXPERIMENTAL allergic encephalitis (EAE) is an inflammatory autoimmunedisease of the central nervous system (CNS) that is mediated by T lymphocytes sensitised to the organ-specific basic protein (BP) of CNS myelin
2
. Lesions of delayed hypersensitivity develop in the brain and spinal cord when sensitised lymphocytes traverse the walls of CNS blood vessels and react with the target antigen in myelin
3
. EAE can be prevented by injecting BP in Freund's incomplete adjuvant (FIA) before challenge, suppressed by injecting BP soon after challenge and treated by injections of BP after clinical symptoms appear
4
. Prevention, suppression and treatment are immunologically specific for BP and can be dissociated from the production of humoral antibody against BP
5
. The demonstration that pretreatment of guinea pigs with bovine spinal cord protein (BSCP)
6,7
prevented the development of EAE
8,9
is thus of considerable importance because BSCP is chemically and antigenically distinct from bovine BP and is not encephalitogenic. As pretreatment with SCP induced a state of nonspecific unresponsiveness to bovine BP in the guinea pig, we investigated whether SCP had anti-encephalitogenic activity in the Lewis rat, a highly inbred rat strain used extensively for the study of EAE. We report here that Lewis rats pre-treated with rat SCP (ref. 10) were protected against EAE, as they did not develop the disease when they were subsequently immunised with rat myelin BP in complete Freund's adjuvant (CFA). |
doi_str_mv | 10.1038/266459a0 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1038_266459a0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-2c5858c3b78fff2b7f4494c2cdd6de8b0bec1e76cc2fb363563084785bf13ef23</originalsourceid><addsrcrecordid>eNplUD1PwzAUtBAVlILEzuIRhoBjO7Y7ooovqRIMMEe281xcpU5kp4X-e1wKLEz3dHfvpDuEzktyXRKmbqgQvJpqcoDGJZei4ELJQzQmhKqCKCaO0UlKS0JIVUp-hEZCVqIaI3iJsIEw-C7gzmH47CH6VSZ0i3XbQlx4iyFY6N916wefsA94Dh_5iHpI2Gx3iHVosOk2PgBOvQ_52XaxwX3sBvAhnaKR022Csx-coLf7u9fZYzF_fnia3c4LS-V0KKitVKUsM1I556iRjvMpt9Q2jWhAGWLAliCFtdQZJlglGFFcqsq4koGjbIIu97k2dilFcHWf2-i4rUtS72aqf2fK1ou9tV-bFTR_xu9dsnq1V1PmwwJivezWMfdK_5O-ADkAcU0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>MACPHERSON, CATHERINE F.C. ; ARMSTRONG, HOLLY</creator><creatorcontrib>MACPHERSON, CATHERINE F.C. ; ARMSTRONG, HOLLY</creatorcontrib><description>EXPERIMENTAL allergic encephalitis (EAE) is an inflammatory autoimmunedisease of the central nervous system (CNS) that is mediated by T lymphocytes sensitised to the organ-specific basic protein (BP) of CNS myelin
2
. Lesions of delayed hypersensitivity develop in the brain and spinal cord when sensitised lymphocytes traverse the walls of CNS blood vessels and react with the target antigen in myelin
3
. EAE can be prevented by injecting BP in Freund's incomplete adjuvant (FIA) before challenge, suppressed by injecting BP soon after challenge and treated by injections of BP after clinical symptoms appear
4
. Prevention, suppression and treatment are immunologically specific for BP and can be dissociated from the production of humoral antibody against BP
5
. The demonstration that pretreatment of guinea pigs with bovine spinal cord protein (BSCP)
6,7
prevented the development of EAE
8,9
is thus of considerable importance because BSCP is chemically and antigenically distinct from bovine BP and is not encephalitogenic. As pretreatment with SCP induced a state of nonspecific unresponsiveness to bovine BP in the guinea pig, we investigated whether SCP had anti-encephalitogenic activity in the Lewis rat, a highly inbred rat strain used extensively for the study of EAE. We report here that Lewis rats pre-treated with rat SCP (ref. 10) were protected against EAE, as they did not develop the disease when they were subsequently immunised with rat myelin BP in complete Freund's adjuvant (CFA).</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/266459a0</identifier><identifier>PMID: 67565</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Encephalomyelitis, Autoimmune, Experimental - prevention & control ; Epitopes ; Humanities and Social Sciences ; Immunization ; letter ; Male ; multidisciplinary ; Myelin Basic Protein - administration & dosage ; Myelin Basic Protein - immunology ; Nerve Tissue Proteins - administration & dosage ; Nerve Tissue Proteins - immunology ; Rats ; Rats, Inbred Lew - immunology ; Rats, Inbred Strains - immunology ; Science ; Species Specificity ; Spinal Cord - immunology</subject><ispartof>Nature (London), 1977-03, Vol.266 (5601), p.459-461</ispartof><rights>Springer Nature Limited 1977</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c279t-2c5858c3b78fff2b7f4494c2cdd6de8b0bec1e76cc2fb363563084785bf13ef23</citedby><cites>FETCH-LOGICAL-c279t-2c5858c3b78fff2b7f4494c2cdd6de8b0bec1e76cc2fb363563084785bf13ef23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/266459a0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/266459a0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/67565$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MACPHERSON, CATHERINE F.C.</creatorcontrib><creatorcontrib>ARMSTRONG, HOLLY</creatorcontrib><title>Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>EXPERIMENTAL allergic encephalitis (EAE) is an inflammatory autoimmunedisease of the central nervous system (CNS) that is mediated by T lymphocytes sensitised to the organ-specific basic protein (BP) of CNS myelin
2
. Lesions of delayed hypersensitivity develop in the brain and spinal cord when sensitised lymphocytes traverse the walls of CNS blood vessels and react with the target antigen in myelin
3
. EAE can be prevented by injecting BP in Freund's incomplete adjuvant (FIA) before challenge, suppressed by injecting BP soon after challenge and treated by injections of BP after clinical symptoms appear
4
. Prevention, suppression and treatment are immunologically specific for BP and can be dissociated from the production of humoral antibody against BP
5
. The demonstration that pretreatment of guinea pigs with bovine spinal cord protein (BSCP)
6,7
prevented the development of EAE
8,9
is thus of considerable importance because BSCP is chemically and antigenically distinct from bovine BP and is not encephalitogenic. As pretreatment with SCP induced a state of nonspecific unresponsiveness to bovine BP in the guinea pig, we investigated whether SCP had anti-encephalitogenic activity in the Lewis rat, a highly inbred rat strain used extensively for the study of EAE. We report here that Lewis rats pre-treated with rat SCP (ref. 10) were protected against EAE, as they did not develop the disease when they were subsequently immunised with rat myelin BP in complete Freund's adjuvant (CFA).</description><subject>Animals</subject><subject>Encephalomyelitis, Autoimmune, Experimental - prevention & control</subject><subject>Epitopes</subject><subject>Humanities and Social Sciences</subject><subject>Immunization</subject><subject>letter</subject><subject>Male</subject><subject>multidisciplinary</subject><subject>Myelin Basic Protein - administration & dosage</subject><subject>Myelin Basic Protein - immunology</subject><subject>Nerve Tissue Proteins - administration & dosage</subject><subject>Nerve Tissue Proteins - immunology</subject><subject>Rats</subject><subject>Rats, Inbred Lew - immunology</subject><subject>Rats, Inbred Strains - immunology</subject><subject>Science</subject><subject>Species Specificity</subject><subject>Spinal Cord - immunology</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1977</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplUD1PwzAUtBAVlILEzuIRhoBjO7Y7ooovqRIMMEe281xcpU5kp4X-e1wKLEz3dHfvpDuEzktyXRKmbqgQvJpqcoDGJZei4ELJQzQmhKqCKCaO0UlKS0JIVUp-hEZCVqIaI3iJsIEw-C7gzmH47CH6VSZ0i3XbQlx4iyFY6N916wefsA94Dh_5iHpI2Gx3iHVosOk2PgBOvQ_52XaxwX3sBvAhnaKR022Csx-coLf7u9fZYzF_fnia3c4LS-V0KKitVKUsM1I556iRjvMpt9Q2jWhAGWLAliCFtdQZJlglGFFcqsq4koGjbIIu97k2dilFcHWf2-i4rUtS72aqf2fK1ou9tV-bFTR_xu9dsnq1V1PmwwJivezWMfdK_5O-ADkAcU0</recordid><startdate>19770331</startdate><enddate>19770331</enddate><creator>MACPHERSON, CATHERINE F.C.</creator><creator>ARMSTRONG, HOLLY</creator><general>Nature Publishing Group UK</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19770331</creationdate><title>Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins</title><author>MACPHERSON, CATHERINE F.C. ; ARMSTRONG, HOLLY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-2c5858c3b78fff2b7f4494c2cdd6de8b0bec1e76cc2fb363563084785bf13ef23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1977</creationdate><topic>Animals</topic><topic>Encephalomyelitis, Autoimmune, Experimental - prevention & control</topic><topic>Epitopes</topic><topic>Humanities and Social Sciences</topic><topic>Immunization</topic><topic>letter</topic><topic>Male</topic><topic>multidisciplinary</topic><topic>Myelin Basic Protein - administration & dosage</topic><topic>Myelin Basic Protein - immunology</topic><topic>Nerve Tissue Proteins - administration & dosage</topic><topic>Nerve Tissue Proteins - immunology</topic><topic>Rats</topic><topic>Rats, Inbred Lew - immunology</topic><topic>Rats, Inbred Strains - immunology</topic><topic>Science</topic><topic>Species Specificity</topic><topic>Spinal Cord - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MACPHERSON, CATHERINE F.C.</creatorcontrib><creatorcontrib>ARMSTRONG, HOLLY</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MACPHERSON, CATHERINE F.C.</au><au>ARMSTRONG, HOLLY</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>1977-03-31</date><risdate>1977</risdate><volume>266</volume><issue>5601</issue><spage>459</spage><epage>461</epage><pages>459-461</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>EXPERIMENTAL allergic encephalitis (EAE) is an inflammatory autoimmunedisease of the central nervous system (CNS) that is mediated by T lymphocytes sensitised to the organ-specific basic protein (BP) of CNS myelin
2
. Lesions of delayed hypersensitivity develop in the brain and spinal cord when sensitised lymphocytes traverse the walls of CNS blood vessels and react with the target antigen in myelin
3
. EAE can be prevented by injecting BP in Freund's incomplete adjuvant (FIA) before challenge, suppressed by injecting BP soon after challenge and treated by injections of BP after clinical symptoms appear
4
. Prevention, suppression and treatment are immunologically specific for BP and can be dissociated from the production of humoral antibody against BP
5
. The demonstration that pretreatment of guinea pigs with bovine spinal cord protein (BSCP)
6,7
prevented the development of EAE
8,9
is thus of considerable importance because BSCP is chemically and antigenically distinct from bovine BP and is not encephalitogenic. As pretreatment with SCP induced a state of nonspecific unresponsiveness to bovine BP in the guinea pig, we investigated whether SCP had anti-encephalitogenic activity in the Lewis rat, a highly inbred rat strain used extensively for the study of EAE. We report here that Lewis rats pre-treated with rat SCP (ref. 10) were protected against EAE, as they did not develop the disease when they were subsequently immunised with rat myelin BP in complete Freund's adjuvant (CFA).</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>67565</pmid><doi>10.1038/266459a0</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-0836 |
ispartof | Nature (London), 1977-03, Vol.266 (5601), p.459-461 |
issn | 0028-0836 1476-4687 |
language | eng |
recordid | cdi_crossref_primary_10_1038_266459a0 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online |
subjects | Animals Encephalomyelitis, Autoimmune, Experimental - prevention & control Epitopes Humanities and Social Sciences Immunization letter Male multidisciplinary Myelin Basic Protein - administration & dosage Myelin Basic Protein - immunology Nerve Tissue Proteins - administration & dosage Nerve Tissue Proteins - immunology Rats Rats, Inbred Lew - immunology Rats, Inbred Strains - immunology Science Species Specificity Spinal Cord - immunology |
title | Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A51%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20experimental%20allergic%20encephalitis%20in%20Lewis%20rats%20by%20rat%20and%20bovine%20spinal%20cord%20proteins&rft.jtitle=Nature%20(London)&rft.au=MACPHERSON,%20CATHERINE%20F.C.&rft.date=1977-03-31&rft.volume=266&rft.issue=5601&rft.spage=459&rft.epage=461&rft.pages=459-461&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/266459a0&rft_dat=%3Cpubmed_cross%3E67565%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/67565&rfr_iscdi=true |